Metozolv ODT approved for diabetic gastroparesis and symptomatic documented gastroesophageal reflux disease (GERD) - MPR

Links shared publicly online about this topic.

  • 1,763
    total visits

Metozolv ODT approved for diabetic gastroparesis and symptomatic documented gastroesophageal reflux disease (GERD) - MPR

empr.com —

The FDA has approved Metozolv ODT (metoclopramide HCl orally disintegrating tablets, from Salix) for short-term therapy (4"12 weeks) in adults with symptomatic, documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy and for the relief of symptoms associated with acute and recurrent diabetic gastroparesis (diabetic gastric stasis) in adults.

View full resource at empr.com

Tags: Nausea and Vomiting Medication, GERD, GERD Medication, Heartburn Medication, Diabetes, Disease and Condition, FDA, Reglan

  • Share

Most Recently Shared on September 8, 2009 at 7:15 pm By:

eMPR MPR

MPR News: Metozolv ODT approved for diabetic gastroparesis and symptomatic documented gastroesophageal .. http://bit.ly/4Pwvi

3 years ago...

Reply

Retweet

Favorite

Orally Dissolving Tablets for Diabetic Gastroparesis Cleared - Renal and Urology News

renalandurologynews.com — “Salix Pharmaceuticals has receiving marketing clearance for Metozolv (metoclopramide HCl) ODT (orally dissolving tablets) 5 mg and 10 mg orally disintegrating tablets for the relief of diabetic gastroparesis and symptomatic documented gastroesophageal reflux (GERD).” View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 4:47 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

Orally Dissolving Tablets for Diabetic Gastroparesis Cleared: Salix Pharmaceuticals has receiving marketing clea.. http://bit.ly/3vljp7

3 years ago...

Reply

Retweet

Favorite

Advertisement